Evidence map›Paper›PMID 37416330›Full record

ArticleJournal of radiosurgery and SBRT2022

Resection cavity dynamics and optimal timing of adjuvant stereotactic radiosurgery for resected brain metastases.

Sujay Rajkumar, Yun Liang, Matthew J Shepard, Richard Williamson, Alexander Yu, Stephen M Karlovits, E Wegner Rodney

Open access · greenAbstract read
In one paragraph

Article in Journal of radiosurgery and SBRT, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sujay RajkumarDrexel University College of Medicine, Philadelphia, PA, USA.
Yun LiangAllegheny Health Network Cancer Institute, Division of Radiation Oncology, Pittsburgh, PA, USA.
Matthew J ShepardAllegheny Health Network, Department of Neurosurgery, Pittsburgh, PA, USA.
Richard WilliamsonAllegheny Health Network, Department of Neurosurgery, Pittsburgh, PA, USA.
Alexander YuAllegheny Health Network, Department of Neurosurgery, Pittsburgh, PA, USA.
Stephen M KarlovitsAllegheny Health Network Cancer Institute, Division of Radiation Oncology, Pittsburgh, PA, USA.
E Wegner RodneyAllegheny Health Network Cancer Institute, Division of Radiation Oncology, Pittsburgh, PA, USA.
Allegheny Health Network · USDrexel University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Optimal timing of SRS after surgical resection of brain metastases (BMs) remains debated but is generally advocated to occur within 4 weeks of surgery to account for cavity remodeling. Our study assesses this recommendation by examining cavity dynamics and any downstream effects on outcome. Methods: Post-operative MRIs were used to compare target lesion volumes to target volume at time of SRS. Spearman's analysis identified a relationship between the time to SRS (ttSRS) and target remodeling. The Mann-Whitney-U test compared median remodeling between groups receiving standard (≤4 weeks) and late (>4 weeks) adjuvant SRS. Kaplan Meier functions estimated probabilities of local recurrence (LR) and survival (OS). A Cox proportional hazards model (CPH) identified predictors of OS, LR, and leptomeningeal disease (LMD). Results: Median ttSRS was 32 days (3-72). A positive correlation exists when comparing ttSRS to reduction in cavity volume (0-10 weeks; p = 0.01) with no difference in median cavity remodeling between standard and late SRS groups. OS and LR rates were respectively 53.3% and 70.2% at 12 months with no difference in OS (p = 0.16) or LR (p = 0.54) between standard and late SRS groups. Subtotal resection predicted LMD (HR: 6.37; p = 0.03). No grade 3 or higher toxicity was seen in follow-up. Conclusion: Resection cavities may continue to shrink well after resection. There is no significant difference in OS or LR based on ttSRS, however, treatment factors such as the extent of resection may account for outcomes such as LMD.

Indexed as

Brain metastasesradiosurgeryradiotherapysurgical resection

Identifiers

PMID37416330
PMCPMC10322174
OpenAlexW4288384987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.